Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

brexit

Brexit negotiations: Is the public’s health a priority?

June 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, brexit, drugs, pharma, pharmaceutical

The Brexit decision has created a huge amount of question marks for many industries and each is vying with each …
Feature
dna-1903319_960_720

Research casts doubts over CRISPR safety

June 12, 2018 Manufacturing and Production, Research and Development biotech, crispr, drugs, pharma, pharmaceutical

Research emerging from two studies, published in same issue of Nature, has raised significant questions over just how safe CRISPR …
News
shutterstock_339308225

Vical terminates genital herpes vaccine after trial failure

June 12, 2018 Manufacturing and Production, Research and Development Vaccine, Vical, herpes, pharma

San Diego-based biopharma firm Vical has announced the disappointing, if unsurprising, news that it has taken the decision to terminate …
News
allergan

Allergan’s atogepant fulfils primary endpoint in episodic migraine

June 12, 2018 Manufacturing and Production, Research and Development Allergan, atogepant, migraine, pharma

Allergan has made ground in its quest to become “the headache company” with the release of new Phase 2b/3 data …
News
nerve-cell-2213009_960_720

Another failure in Alzheimer’s creates bleak outlook for treatment

June 12, 2018 Manufacturing and Production, Research and Development Alzheimer's, AstraZeneca, Eli Lilly, biotech, drugs, pharma, pharmaceutical

Finding a treatment for Alzheimer’s disease has been one of the aims of big pharma for last few decades, but …
News
top_ten

Top Ten most popular articles on Pharmafile.com this week

June 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

With ASCO occurring over the weekend, the headlines this week have been dominated by the news of breaking research that …
News
nerves

Parkinson’s disease: A quest for steadier therapies

June 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Parkinson's disease, biotech, drugs, pharma, pharmaceutical

The worrying number of deaths associated with Nuplazid has eyes returning to the pipeline for Parkinson’s disease. Anjali Shukla, a …
Feature

Pfizer pumps $600m into venture fund, targeting neuroscience

June 7, 2018 Research and Development, Sales and Marketing Pfizer, biotech, drugs, neuroscience, pharma, pharmaceutical

Pfizer’s move to dump its neuroscience divisions caused serious ripples through the industry, with many wondering whether it heralded an …
News
money-2180330_960_720

Forty Seven springs out of the blocks ahead of IPO

June 7, 2018 Research and Development, Sales and Marketing Forty Seven, biotech, drugs, pharma, pharmaceutical

Forty Seven, a spinout from Stanford University, has had a busy few days – first announcing that it had filed …
News

FlyPharma Conference Europe concludes its fourth successful year in Brussels

June 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, flypharma, pharma, pharmaceutical

The FlyPharma Conference Europe wrapped up for another year on 6 June, returning with an expanded roster of speakers who …
News
allergan-irvine-california-2_0

Allergan mauled by investors in public letter

June 6, 2018 Medical Communications, Research and Development Allergan

Last week, Allergan announced that a strategic review of its operations had led to a decision to divest its women’s …
News
mylan_inside_0

Mylan lands biosimilar sucker punch to Amgen’s blockbuster

June 6, 2018 Research and Development, Sales and Marketing Amgen, Biocon, Mylan, Neulasta

Mylan and Biocon have received FDA approval for their biosimilar to Amgen’s Neulasta (pegfilgrastim), setting the companies on track to …
News
astrazeneca_sign_sky

AZ and MSD impress at ASCO with Lynparza combo data in prostate cancer

June 5, 2018 Research and Development ASCO, AstraZeneca, Cancer, MSD< pharma, Merck, lynparza, prostate cancer

In another major ASCO reveal, AstraZeneca and partner MSD lifted the curtain at the event on new data for its …
News

NICE recommends MSD’s Keytruda for advanced PD-L1-positive lung cancer

June 5, 2018 Research and Development MSD, Merck, NHS, NICE, keytruda, pharma

UK drug watchdog NICE has chosen to issue final guidance recommending the use of MSD’s Keytruda (pembrolizumab) on the NHS …
News

Eli Lilly’s President of Oncology to retire

June 5, 2018 Research and Development Cancer, Eli Lilly, appointment, oncology, pharma

Just as it ramps up its cancer-fighting efforts, Eli Lilly has revealed that its Senior Vice President and President of …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026